首页> 外文期刊>World Journal of Gastroenterology >Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma.
【24h】

Tissue microarray for high-throughput analysis of gene expression profiles in hepatocellular carcinoma.

机译:组织芯片用于肝细胞癌基因表达谱的高通量分析。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To study the expression profiles of HBsAg, HBcAg, p21(WAF1/CIP1) (p21), Rb genes in hepatocellular carcinoma (HCC) and to investigate their roles in the hepatocar-cinogenesis. METHODS: HCC tissue microarray containing 120-min tissues of 40 HCC cases was constructed. HBsAg, HBcAg, p21 and Rb proteins were immunohistochemically stained by streptavidin-peroxidase conjugated method (S-P). The expression loss of these genes in cancerous, para-cancerous tissues and adjacent normal liver tissues of 40 HCCs were comparatively examined. RESULTS: The positive rate of HBsAg expression in cancerous tissues of 40 HCCs was 7.5%, which was lower than that in para-cancerous and adjacent normal liver tissues (chi(2) =12.774, P<0.01; chi(2) = 18.442, P<0.01). The positive rate of HBcAg expression in cancerous tissues of 40 HCCs was 20.0%, which was also lower than that in para-cancerous and adjacent normal liver tissues (chi(2) = 9.482, P<0.01; chi(2) = 14.645, P<0.01). p21 protein deletion rate in cancerous tissues of 40 HCCs was 27.5%, which was higher than that in para-cancerous and adjacent normal liver tissues (chi(2) = 7.439, P<0.01; chi(2) = 11.174, P<0.01). p21 protein deletion correlated remarkably with the pathological grade of HCC (chi(2) = 0.072, P<0.05). Rb protein deletion rate in cancerous tissues of 40 HCCs was 42.5%, which was also higher than that in para-cancerous and adjacent normal liver tissues (chi(2) = 10.551, P<0.01; chi(2) = 18.353, P<0.01). Rb protein deletion rate did not correlate remarkably with tumor size or pathological grade of HCC (chi(2) = 0.014, P>0.05; chi(2) = 0.017, P>0.05). CONCLUSION: Expression deletion of HBsAg, HBcAg, p21 and Rb proteins in HCCs may play important roles in the carcinogenesis of HCC. Tissue microarray is an effective high-throughput technique platform for cancer research.
机译:目的:研究HBsAg,HBcAg,p21(WAF1 / CIP1)(p21),Rb基因在肝细胞癌(HCC)中的表达情况,并探讨其在肝癌发生中的作用。方法:构建包含40例HCC患者120分钟组织的HCC组织微阵列。 HBsAg,HBcAg,p21和Rb蛋白通过链霉亲和素-过氧化物酶偶联方法(S-P)进行免疫组织化学染色。比较检查了这些基因在40例HCC癌,癌旁组织和邻近的正常肝组织中的表达损失。结果:40例肝癌组织中HBsAg阳性表达率为7.5%,低于癌旁及癌旁正常肝组织(chi(2)= 12.774,P <0.01; chi(2)= 18.442)。 ,P <0.01)。 40例HCC癌组织中HBcAg表达阳性率为20.0%,也低于癌旁及邻近正常肝组织的HBcAg表达阳性率(chi(2)= 9.482,P <0.01; chi(2)= 14.645, P <0.01)。 40例肝癌的癌组织中p21蛋白的缺失率为27.5%,高于癌旁及癌旁正常肝组织的p21蛋白缺失率(chi(2)= 7.439,P <0.01; chi(2)= 11.174,P <0.01 )。 p21蛋白的缺失与肝癌的病理分级显着相关(chi(2)= 0.072,P <0.05)。 40个HCC癌组织中Rb蛋白的缺失率为42.5%,也高于癌旁及邻近正常肝组织中的Rb蛋白缺失率(chi(2)= 10.551,P <0.01; chi(2)= 18.353,P < 0.01)。 Rb蛋白缺失率与HCC的肿瘤大小或病理分级无显着相关性(chi(2)= 0.014,P> 0.05; chi(2)= 0.017,P> 0.05)。结论:肝癌中HBsAg,HBcAg,p21和Rb蛋白的表达缺失可能在肝癌的发生中起重要作用。组织芯片是用于癌症研究的有效的高通量技术平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号